Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety an... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818993) titled 'Effects of Functional Magnetic Stimulation in Sensory and Motor Function in Diabethic Neur... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818447) titled 'Alveolar Ridge Preservation Using Bone Allografts With a PRF Membrane Versus GBR: A Random... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety an... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety an... Read More
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817550) titled 'Multimodal Digital Biomarker Prediction of Acute Clinical Deterioration' on Sept. 01. Bri... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral n... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozanti... Read More
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More